Litcius/Paper detail

Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score

Cameron D. Thomas, Francesco Franchi, Joseph S. Rossi, Ellen C. Keeley, R. David Anderson, Amber L. Beitelshees, Julio D. Duarte, Luis Ortega‐Paz, Yan Gong, Richard A. Kerensky, Natasha Kulick, Caitrin W. McDonough, Anh B. Nguyen, Yehua Wang, Marshall Winget, William Yang, Julie A. Johnson, Almut G. Winterstein, George A. Stouffer, Dominick J. Angiolillo, Craig R. Lee, Larisa H. Cavallari

2024Journal of the American College of Cardiology24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineClopidogrelPercutaneous coronary interventionPrasugrelInternal medicineConventional PCITicagrelorCYP2C19Propensity score matchingP2Y12CardiologyAspirinMyocardial infarctionMetabolismCytochrome P450Antiplatelet Therapy and Cardiovascular DiseasesAtrial Fibrillation Management and OutcomesPharmacogenetics and Drug Metabolism
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score | Litcius